
Brain Key is pioneering an innovative approach to brain health and longevity management by quantifying brain health through advanced MRI and genetic analysis. The company provides personalized treatment recommendations based on AI-derived brain biomarkers, aiming to transform how brain disorders are identified and managed. With a mission to address the global challenge of cognitive decline, Brain Key equips physicians with tools to prevent dementia, impacting over a billion people worldwide. Their platform offers 3D visualizations of brain scans, actionable insights, and a unique genetic analysis feature, positioning them as a leader in the brain health technology market.

Brain Key is pioneering an innovative approach to brain health and longevity management by quantifying brain health through advanced MRI and genetic analysis. The company provides personalized treatment recommendations based on AI-derived brain biomarkers, aiming to transform how brain disorders are identified and managed. With a mission to address the global challenge of cognitive decline, Brain Key equips physicians with tools to prevent dementia, impacting over a billion people worldwide. Their platform offers 3D visualizations of brain scans, actionable insights, and a unique genetic analysis feature, positioning them as a leader in the brain health technology market.
What they do: AI-driven analysis of brain MRI and genetic data to generate personalized brain health biomarkers and treatment recommendations
Founders / leadership: Founded by neuroscientist Owen Phillips, PhD; Nathan Strong, PhD is listed as Founder & CTO; Crunchbase also lists Ben Kotopka as a co‑founder
Acceleration / HQ: Accepted into Y Combinator in 2019; principal place of business in San Francisco, CA
Team size: Approximately 16 employees
Funding: Total funding listed as 200000.00 USD; latest reported round a Convertible Note on 2021-12-01
Cognitive decline and dementia risk assessment and management
Listed as a pre-seed round in Aug 2018
Seed round announced Mar 18, 2019 (closed Apr 12, 2019)
Latest listed round (Convertible Note) on Dec 1, 2021
“Backed by early-stage investors and accelerators including Y Combinator, Social Starts, and Longevitytech.fund”